arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

BillionToOne, Inc.

BLLN
$93.36 ▲ +1.71 (+1.87%) at close
Healthcare ·Services-Medical Laboratories ·USServices-Medical Laboratories
4 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
57
Health
Fair
Bullish
auto_awesome

Analytical Summary

BillionToOne, Inc. shows strong fundamentals with top-quartile Debt to Equity. The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $1.5B
Dividend Yield
Revenue Growth 100.0%
Op. Margin 5.3%
ROIC 2.9%
FCF / Share $0.99
Trailing P/E 518.7x
Price / Book 3.1x
FCF Yield 1.1%
Debt / Equity 0.12
info Valuation on last close. End-of-day price, Aug 7, 2026.

4-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$305.11M
↑ +100.0%
Net Income Profit after all expenses
$7.45M
↑ +117.9%
Operating Margin Operating profit as % of sales
5.3%
↑ +117.0% 43th
FCF / Share Free cash flow per share
$0.99
↑ +121.3%
Long-Term Debt Long-term obligations
$57.23M
↑ +11.2%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
43
Returns
47
Financial Health
74
Cash Quality
87

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 4 years · 10 quarters